1. Home
  2. BE vs GKOS Comparison

BE vs GKOS Comparison

Compare BE & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BE
  • GKOS
  • Stock Information
  • Founded
  • BE 2001
  • GKOS 1998
  • Country
  • BE United States
  • GKOS United States
  • Employees
  • BE N/A
  • GKOS N/A
  • Industry
  • BE Industrial Machinery/Components
  • GKOS Medical/Dental Instruments
  • Sector
  • BE Energy
  • GKOS Health Care
  • Exchange
  • BE Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • BE 5.1B
  • GKOS 5.8B
  • IPO Year
  • BE 2018
  • GKOS 2015
  • Fundamental
  • Price
  • BE $45.28
  • GKOS $89.83
  • Analyst Decision
  • BE Buy
  • GKOS Strong Buy
  • Analyst Count
  • BE 17
  • GKOS 12
  • Target Price
  • BE $27.26
  • GKOS $131.17
  • AVG Volume (30 Days)
  • BE 12.6M
  • GKOS 1.2M
  • Earning Date
  • BE 07-31-2025
  • GKOS 07-30-2025
  • Dividend Yield
  • BE N/A
  • GKOS N/A
  • EPS Growth
  • BE N/A
  • GKOS N/A
  • EPS
  • BE 0.10
  • GKOS N/A
  • Revenue
  • BE $1,630,054,000.00
  • GKOS $432,953,000.00
  • Revenue This Year
  • BE $21.86
  • GKOS $27.88
  • Revenue Next Year
  • BE $21.05
  • GKOS $27.76
  • P/E Ratio
  • BE $440.09
  • GKOS N/A
  • Revenue Growth
  • BE 22.72
  • GKOS 26.70
  • 52 Week Low
  • BE $9.02
  • GKOS $77.10
  • 52 Week High
  • BE $47.16
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • BE 81.14
  • GKOS 43.89
  • Support Level
  • BE $41.42
  • GKOS $88.94
  • Resistance Level
  • BE $46.50
  • GKOS $92.70
  • Average True Range (ATR)
  • BE 3.01
  • GKOS 3.82
  • MACD
  • BE 0.64
  • GKOS 0.38
  • Stochastic Oscillator
  • BE 86.83
  • GKOS 46.71

About BE Bloom Energy Corporation

Bloom Energy designs, manufactures, sells, and installs solid-oxide fuel cell systems ("Energy Servers") for on-site power generation. Bloom Energy Servers are fuel-flexible and can use natural gas, biogas, and hydrogen to create 24/7 electricity for stationary applications. In 2021, the company announced plans to leverage its technology and enter the electrolyzer market. Bloom primarily sells its systems in the United States and internationally.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: